Partner Xiangxiang Ma of Anjie Broad Law Firm examines the advantages and disadvantages of two key approaches to the legal protection of vital AI algorithms ...

China’s draft pharmaceutical trial rules aim to balance innovation with drug availability; CAC issues first rules to regulate ...

China to block Chinese firms from investing in the U.S. amid tariff war; Shenzhen launches incentives for foreign-owned ...

Cybersecurity Law amendment draft imposes heavier penalties. China proposes different data protection periods for three categories of drugs. Facial information collection requires obligations of ...

Where an organization or individual in mainland China is involved in a legal action relating to foreign 1-related intellectual property or is investigated by a foreign judicial or law enforcement ...

Jin and Haoyi Sun of Zhong Lun Law Firm discuss the reasons behind, and the implications of, Illumina’s inclusion in China’s Unreliable Entity List, as well as compliance recommendations for multinati ...

State Council, Provisions for Implementation of the «PRC Anti-Foreign Sanctions Law» 国务院实施〈中华人民共和国反外国制裁法〉的规定 Where ...